Fibromyalgia & musculoskeletal pain
The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative
Authors' conclusion
There was broad agreement that, in a substantial proportion of patients with inflammatory arthritis, nociplastic pain persists despite optimal treatment, is challenging to manage in routine clinical practice, and is associated with substantial patient suffering.
Study context
- Population
- Participants attending the OMERACT 2025 pain SIG session: patients, clinicians, researchers, methodologists and industry representativesincl
- Participants
- 24 participants
- Outcome
- Stakeholder polling on nociplastic pain definition and measurement in IA
Methodological detailsOMERACT special interest group session with stakeholder polling, OMERACT 2025 pain SIG
- OMERACT special interest group session with stakeholder polling
- OMERACT 2025 pain SIG
Recommendations
As reported in the abstract
- Endorsed beginning with a systematic review of existing literature to identify a validated instrument
- 86 %, 19/24
- PRPs able to report the different pain types experienced in IA after pain neuroscience education
- 5/6 (83 %)
- Agreed current IASP nociplastic pain definition is directly applicable to IA
- 1/24
- Disagreed or uncertain about direct applicability of IASP definition
- 96 %
- Felt the definition likely requires contextualisation for IA
- 14/24
Original publication
The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative. Semin Arthritis Rheum. Published 6 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →